Why Investors Shouldn't Be Surprised By Atrys Health, S.A.'s (BME:ATRY) P/S
Dec 25
Have your own idea? Try our Stock Screener
Spanish (IBEX) Healthcare Sector Analysis
UpdatedDec 25, 2024
DataAggregated Company Financials
Companies14
- 7D-1.9%
- 3M-2.1%
- 1Y-13.8%
- YTD-16.1%
Over the last 7 days, the Healthcare industry has dropped 3.1%, driven by a pullback from Grifols of 5.3%. Meanwhile, Atrys Health actually outperformed within the industry, gaining 9.7% in the last week. The industry has fallen 14% in the last year. Earnings are forecast to grow by 35% annually.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 25 Dec 2024 | €14.4b | €10.6b | €392.4m | 19.1x | 36.8x | 1.4x |
| Fri, 22 Nov 2024 | €15.1b | €10.5b | €393.8m | 19.2x | 38.4x | 1.4x |
| Sun, 20 Oct 2024 | €16.0b | €10.2b | €394.8m | 16.4x | 40.4x | 1.6x |
| Tue, 17 Sep 2024 | €15.2b | €10.2b | €399.9m | 14.4x | 38x | 1.5x |
| Thu, 15 Aug 2024 | €13.8b | €10.2b | €399.9m | 15x | 34.5x | 1.4x |
| Sat, 13 Jul 2024 | €15.8b | €10.0b | €405.9m | 19.8x | 39x | 1.6x |
| Mon, 10 Jun 2024 | €15.6b | €10.0b | €401.4m | 21.1x | 38.8x | 1.6x |
| Wed, 08 May 2024 | €14.6b | €10.0b | €301.0m | 17.7x | 48.6x | 1.5x |
| Fri, 05 Apr 2024 | €14.2b | €10.0b | €292.0m | 21.4x | 48.5x | 1.4x |
| Sun, 03 Mar 2024 | €13.8b | €10.0b | €284.5m | 21x | 48.4x | 1.4x |
| Tue, 30 Jan 2024 | €14.1b | €10.0b | €332.5m | 17.2x | 42.4x | 1.4x |
| Thu, 28 Dec 2023 | €16.4b | €10.0b | €332.6m | 17.3x | 49.2x | 1.6x |
| Sat, 25 Nov 2023 | €15.4b | €10.0b | €331.6m | 17.4x | 46.6x | 1.6x |
| Mon, 23 Oct 2023 | €13.5b | €9.8b | €302.1m | 17.4x | 44.6x | 1.4x |
| Wed, 20 Sep 2023 | €15.7b | €9.8b | €311.0m | 19.3x | 50.5x | 1.6x |
| Fri, 18 Aug 2023 | €15.6b | €9.8b | €311.0m | 19.8x | 50.1x | 1.6x |
| Sun, 16 Jul 2023 | €13.8b | €9.6b | €364.7m | 20.2x | 38x | 1.4x |
| Tue, 13 Jun 2023 | €13.7b | €9.6b | €364.5m | 20.9x | 37.5x | 1.4x |
| Thu, 11 May 2023 | €13.3b | €9.3b | €533.7m | 21.2x | 24.9x | 1.4x |
| Sat, 08 Apr 2023 | €12.4b | €9.3b | €563.7m | 18.9x | 22.1x | 1.3x |
| Mon, 06 Mar 2023 | €14.1b | €9.3b | €564.2m | 20.9x | 25x | 1.5x |
| Wed, 01 Feb 2023 | €14.6b | €8.4b | €430.6m | 13.7x | 33.8x | 1.7x |
| Fri, 30 Dec 2022 | €13.8b | €8.4b | €430.5m | 13.7x | 32.2x | 1.7x |
| Sun, 27 Nov 2022 | €13.7b | €8.4b | €433.1m | 14.5x | 31.6x | 1.6x |
| Tue, 25 Oct 2022 | €12.3b | €8.4b | €462.3m | 13.3x | 26.7x | 1.5x |
| Thu, 22 Sep 2022 | €14.6b | €8.3b | €461.7m | 13.6x | 31.5x | 1.8x |
| Sat, 20 Aug 2022 | €16.1b | €8.3b | €465.4m | 14.4x | 34.5x | 1.9x |
| Mon, 18 Jul 2022 | €18.6b | €7.9b | €514.1m | 14.5x | 36.1x | 2.3x |
| Wed, 15 Jun 2022 | €18.6b | €7.9b | €513.8m | 13.8x | 36.2x | 2.3x |
| Fri, 13 May 2022 | €20.4b | €7.8b | €485.6m | 14.1x | 42.1x | 2.6x |
| Sun, 10 Apr 2022 | €19.7b | €7.8b | €487.8m | 14.6x | 40.3x | 2.5x |
| Tue, 08 Mar 2022 | €18.8b | €7.8b | €506.8m | 13.2x | 37.2x | 2.4x |
| Thu, 03 Feb 2022 | €18.9b | €7.9b | €932.5m | 16.5x | 20.3x | 2.4x |
| Sat, 01 Jan 2022 | €19.7b | €7.9b | €932.0m | 17.3x | 21.1x | 2.5x |
Price to Earnings Ratio
21.1x
Current Industry PE
- Investors are relatively neutral on the Spanish Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 37.2x.
- The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 25% per year over the last three years.
- Meanwhile revenues for these companies have grown 10% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | -0.86% | |
| Healthcare | -1.90% | |
| Healthcare Services | 1.75% | |
| Healthtech | 0% | |
| Pharma | -0.13% | |
| Medical Equipment | -1.78% | |
| Life Sciences | -2.84% | |
| Biotech | -3.71% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 46.3x.
- Analysts are expecting annual earnings growth of 91.4%, which is higher than its past year's earnings growth of 14.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 91% over the next 5 years.
- This is better than its past earnings growth rate of 15% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 26% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHM Pharma Mar | €79.90 | 4.4% +€59.6m | 86.4% | PE2253x | |
| ATRY Atrys Health | €3.44 | 11.0% +€25.8m | -8.3% | PS1.2x | |
| ROVI Laboratorios Farmaceuticos Rovi | €61.70 | 0.4% +€12.8m | 3.6% | PE19.1x |
